CBS writes:
Dr. David Kessler, the FDA commissioner in the 1990s at the time Purdue’s powerful, long-acting opioid OxyContin was first approved, says the FDA never should have allowed the drug and others like it to be broadly marketed for chronic pain patients. The agency erred in radically extending the market for opioids despite the lack of studies on the safety and efficacy for long term use, he says. The former commissioner says the label on opioid drugs must be changed to limit the ability of drug companies’ to market opioids. “It needs to be done,” he says.